Provention bio announces appointment of thierry chauche as chief financial officer

Red bank, n.j., nov. 4, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that thierry chauche will become chief financial officer effective december 1, 2021 and andrew drechsler will be retiring, following a career of nearly 30 years in the financial and life sciences industry, most notably, the past four years at provention bio.
PRVB Ratings Summary
PRVB Quant Ranking